Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer
Clinical trial NCT00450008 · TERMINATED
Trial details
- NCT number
- NCT00450008
- Sponsor
- The Methodist Hospital Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-08-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.